Selected research
Market Structure
Global Medical Diagnostic Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Diagnostic Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Medical Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Diagnostic Software include Osplabs, CrelioHealth, Human Dx, Empeek, Folio3 AI, Isabel Healthcare, SysGears, PC Connection and Folio3, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Medical Diagnostic Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Diagnostic Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Diagnostic Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Diagnostic Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Diagnostic Software Segment by Company
Osplabs
CrelioHealth
Human Dx
Empeek
Folio3 AI
Isabel Healthcare
SysGears
PC Connection
Folio3
PathAI
Nanox Imaging（Zebra Medical Vision）
DreaMed Diabetes
Healthvisors
Butterfly Network
Ada Health
Buoy Health
Medical Diagnostic Software Segment by Type
Medical Imaging-Assisted Diagnostic Software
Physiological Signal Analysis Diagnostic Software
Laboratory Data-Assisted Diagnostic Software
Clinical Decision Support System (CDSS)
Medical Diagnostic Software Segment by Application
Hospital
Clinic
Others
Medical Diagnostic Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Diagnostic Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Diagnostic Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Diagnostic Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Diagnostic Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Diagnostic Software industry.
Chapter 3: Detailed analysis of Medical Diagnostic Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Diagnostic Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Imaging-Assisted Diagnostic Software
- Physiological Signal Analysis Diagnostic Software
- Laboratory Data-Assisted Diagnostic Software
- Clinical Decision Support System (CDSS)
Applications
- Hospital
- Clinic
- Others
Companies covered
- Osplabs
- CrelioHealth
- Human Dx
- Empeek
- Folio3 AI
- Isabel Healthcare
- SysGears
- PC Connection
- Folio3
- PathAI
- Nanox Imaging（Zebra Medical Vision）
- DreaMed Diabetes
- Healthvisors
- Butterfly Network
- Ada Health
- Buoy Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Medical Diagnostic Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Medical Imaging-Assisted Diagnostic Software
- 1.2.3 Physiological Signal Analysis Diagnostic Software
- 1.2.4 Laboratory Data-Assisted Diagnostic Software
- 1.2.5 Clinical Decision Support System (CDSS)
- 1.3 Market Analysis by Application
- 1.3.1 Global Medical Diagnostic Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Medical Diagnostic Software Growth Trends by Region
- 1.5.1 Global Medical Diagnostic Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Medical Diagnostic Software Market Size by Region (2021-2026)
- 1.5.3 Medical Diagnostic Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Medical Diagnostic Software Market Dynamics
- 2.1 Medical Diagnostic Software Industry Trends
- 2.2 Medical Diagnostic Software Industry Drivers
- 2.3 Medical Diagnostic Software Industry Opportunities and Challenges
- 2.4 Medical Diagnostic Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Medical Diagnostic Software Revenue by Company (2021-2026)
- 3.2 Global Medical Diagnostic Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Medical Diagnostic Software Key Company Head office and Area Served
- 3.4 Global Medical Diagnostic Software Company, Product Type & Application
- 3.5 Global Medical Diagnostic Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Medical Diagnostic Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Medical Diagnostic Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Medical Diagnostic Software Tier 1, Tier 2, and Tier 3
4 Medical Diagnostic Software Market by Type
- 4.1 Global Medical Diagnostic Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Medical Diagnostic Software Market Size by Type (2021-2032)
- 4.3 Global Medical Diagnostic Software Market Size Share by Type (2021-2032)
5 Medical Diagnostic Software Market by Application
- 5.1 Global Medical Diagnostic Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Medical Diagnostic Software Market Size by Application (2021-2032)
- 5.3 Global Medical Diagnostic Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Osplabs
- 6.1.1 Osplabs Company Information
- 6.1.2 Osplabs Business Overview
- 6.1.3 Osplabs Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Osplabs Medical Diagnostic Software Product Portfolio
- 6.1.5 Osplabs Recent Developments
- 6.2 CrelioHealth
- 6.2.1 CrelioHealth Company Information
- 6.2.2 CrelioHealth Business Overview
- 6.2.3 CrelioHealth Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CrelioHealth Medical Diagnostic Software Product Portfolio
- 6.2.5 CrelioHealth Recent Developments
- 6.3 Human Dx
- 6.3.1 Human Dx Company Information
- 6.3.2 Human Dx Business Overview
- 6.3.3 Human Dx Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Human Dx Medical Diagnostic Software Product Portfolio
- 6.3.5 Human Dx Recent Developments
- 6.4 Empeek
- 6.4.1 Empeek Company Information
- 6.4.2 Empeek Business Overview
- 6.4.3 Empeek Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Empeek Medical Diagnostic Software Product Portfolio
- 6.4.5 Empeek Recent Developments
- 6.5 Folio3 AI
- 6.5.1 Folio3 AI Company Information
- 6.5.2 Folio3 AI Business Overview
- 6.5.3 Folio3 AI Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Folio3 AI Medical Diagnostic Software Product Portfolio
- 6.5.5 Folio3 AI Recent Developments
- 6.6 Isabel Healthcare
- 6.6.1 Isabel Healthcare Company Information
- 6.6.2 Isabel Healthcare Business Overview
- 6.6.3 Isabel Healthcare Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Isabel Healthcare Medical Diagnostic Software Product Portfolio
- 6.6.5 Isabel Healthcare Recent Developments
- 6.7 SysGears
- 6.7.1 SysGears Company Information
- 6.7.2 SysGears Business Overview
- 6.7.3 SysGears Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SysGears Medical Diagnostic Software Product Portfolio
- 6.7.5 SysGears Recent Developments
- 6.8 PC Connection
- 6.8.1 PC Connection Company Information
- 6.8.2 PC Connection Business Overview
- 6.8.3 PC Connection Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 PC Connection Medical Diagnostic Software Product Portfolio
- 6.8.5 PC Connection Recent Developments
- 6.9 Folio3
- 6.9.1 Folio3 Company Information
- 6.9.2 Folio3 Business Overview
- 6.9.3 Folio3 Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Folio3 Medical Diagnostic Software Product Portfolio
- 6.9.5 Folio3 Recent Developments
- 6.10 Google
- 6.10.1 Google Company Information
- 6.10.2 Google Business Overview
- 6.10.3 Google Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Google Medical Diagnostic Software Product Portfolio
- 6.10.5 Google Recent Developments
- 6.11 PathAI
- 6.11.1 PathAI Company Information
- 6.11.2 PathAI Business Overview
- 6.11.3 PathAI Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 PathAI Medical Diagnostic Software Product Portfolio
- 6.11.5 PathAI Recent Developments
- 6.12 Nanox Imaging（Zebra Medical Vision）
- 6.12.1 Nanox Imaging（Zebra Medical Vision） Company Information
- 6.12.2 Nanox Imaging（Zebra Medical Vision） Business Overview
- 6.12.3 Nanox Imaging（Zebra Medical Vision） Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Nanox Imaging（Zebra Medical Vision） Medical Diagnostic Software Product Portfolio
- 6.12.5 Nanox Imaging（Zebra Medical Vision） Recent Developments
- 6.13 DreaMed Diabetes
- 6.13.1 DreaMed Diabetes Company Information
- 6.13.2 DreaMed Diabetes Business Overview
- 6.13.3 DreaMed Diabetes Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 DreaMed Diabetes Medical Diagnostic Software Product Portfolio
- 6.13.5 DreaMed Diabetes Recent Developments
- 6.14 Healthvisors
- 6.14.1 Healthvisors Company Information
- 6.14.2 Healthvisors Business Overview
- 6.14.3 Healthvisors Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Healthvisors Medical Diagnostic Software Product Portfolio
- 6.14.5 Healthvisors Recent Developments
- 6.15 Butterfly Network
- 6.15.1 Butterfly Network Company Information
- 6.15.2 Butterfly Network Business Overview
- 6.15.3 Butterfly Network Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Butterfly Network Medical Diagnostic Software Product Portfolio
- 6.15.5 Butterfly Network Recent Developments
- 6.16 Ada Health
- 6.16.1 Ada Health Company Information
- 6.16.2 Ada Health Business Overview
- 6.16.3 Ada Health Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Ada Health Medical Diagnostic Software Product Portfolio
- 6.16.5 Ada Health Recent Developments
- 6.17 Buoy Health
- 6.17.1 Buoy Health Company Information
- 6.17.2 Buoy Health Business Overview
- 6.17.3 Buoy Health Medical Diagnostic Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Buoy Health Medical Diagnostic Software Product Portfolio
- 6.17.5 Buoy Health Recent Developments
7 North America
- 7.1 North America Medical Diagnostic Software Market Size (2021-2032)
- 7.2 North America Medical Diagnostic Software Market Size by Type
- 7.2.1 North America Medical Diagnostic Software Market Size by Type (2021-2026)
- 7.2.2 North America Medical Diagnostic Software Market Size by Type (2027-2032)
- 7.2.3 North America Medical Diagnostic Software Market Share by Type (2021-2032)
- 7.3 North America Medical Diagnostic Software Market Size by Application
- 7.3.1 North America Medical Diagnostic Software Market Size by Application (2021-2026)
- 7.3.2 North America Medical Diagnostic Software Market Size by Application (2027-2032)
- 7.3.3 North America Medical Diagnostic Software Market Share by Application (2021-2032)
- 7.4 North America Medical Diagnostic Software Market Size by Country
- 7.4.1 North America Medical Diagnostic Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Medical Diagnostic Software Market Size by Country (2021-2026)
- 7.4.3 North America Medical Diagnostic Software Market Size by Country (2027-2032)
- 7.4.4 North America Medical Diagnostic Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Medical Diagnostic Software Market Size (2021-2032)
- 8.2 Europe Medical Diagnostic Software Market Size by Type
- 8.2.1 Europe Medical Diagnostic Software Market Size by Type (2021-2026)
- 8.2.2 Europe Medical Diagnostic Software Market Size by Type (2027-2032)
- 8.2.3 Europe Medical Diagnostic Software Market Share by Type (2021-2032)
- 8.3 Europe Medical Diagnostic Software Market Size by Application
- 8.3.1 Europe Medical Diagnostic Software Market Size by Application (2021-2026)
- 8.3.2 Europe Medical Diagnostic Software Market Size by Application (2027-2032)
- 8.3.3 Europe Medical Diagnostic Software Market Share by Application (2021-2032)
- 8.4 Europe Medical Diagnostic Software Market Size by Country
- 8.4.1 Europe Medical Diagnostic Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Medical Diagnostic Software Market Size by Country (2021-2026)
- 8.4.3 Europe Medical Diagnostic Software Market Size by Country (2027-2032)
- 8.4.4 Europe Medical Diagnostic Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Medical Diagnostic Software Market Size (2021-2032)
- 9.2 China Medical Diagnostic Software Market Size by Type
- 9.2.1 China Medical Diagnostic Software Market Size by Type (2021-2026)
- 9.2.2 China Medical Diagnostic Software Market Size by Type (2027-2032)
- 9.2.3 China Medical Diagnostic Software Market Share by Type (2021-2032)
- 9.3 China Medical Diagnostic Software Market Size by Application
- 9.3.1 China Medical Diagnostic Software Market Size by Application (2021-2026)
- 9.3.2 China Medical Diagnostic Software Market Size by Application (2027-2032)
- 9.3.3 China Medical Diagnostic Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Medical Diagnostic Software Market Size (2021-2032)
- 10.2 Asia Medical Diagnostic Software Market Size by Type
- 10.2.1 Asia Medical Diagnostic Software Market Size by Type (2021-2026)
- 10.2.2 Asia Medical Diagnostic Software Market Size by Type (2027-2032)
- 10.2.3 Asia Medical Diagnostic Software Market Share by Type (2021-2032)
- 10.3 Asia Medical Diagnostic Software Market Size by Application
- 10.3.1 Asia Medical Diagnostic Software Market Size by Application (2021-2026)
- 10.3.2 Asia Medical Diagnostic Software Market Size by Application (2027-2032)
- 10.3.3 Asia Medical Diagnostic Software Market Share by Application (2021-2032)
- 10.4 Asia Medical Diagnostic Software Market Size by Country
- 10.4.1 Asia Medical Diagnostic Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Medical Diagnostic Software Market Size by Country (2021-2026)
- 10.4.3 Asia Medical Diagnostic Software Market Size by Country (2027-2032)
- 10.4.4 Asia Medical Diagnostic Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Medical Diagnostic Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Medical Diagnostic Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Medical Diagnostic Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Medical Diagnostic Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Medical Diagnostic Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Medical Diagnostic Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Medical Diagnostic Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Medical Diagnostic Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Medical Diagnostic Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Medical Diagnostic Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Medical Diagnostic Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Medical Diagnostic Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Medical Diagnostic Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Medical Diagnostic Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst